
1. malar j. 2019 nov 27;18(1):378. doi: 10.1186/s12936-019-3012-7.

tamoxifen activity plasmodium vitro mice.

weinstock a(1), gallego-delgado j(2)(3)(4), gomes c(5), sherman j(5), nikain
c(1), gonzalez s(5), fisher e(1), rodriguez a(5).

author information: 
(1)departments medicine (cardiology) cell biology, marc ruti
bell program vascular biology, new york university school medicine, new
york, ny, 10016, usa.
(2)department biological sciences, lehman college, city university new
york, bronx, new york, ny, 10468, usa. julio.gallegodelgado@lehman.cuny.edu.
(3)ph.d. program biology, graduate center, city university new
york, new york, ny, 10016, usa. julio.gallegodelgado@lehman.cuny.edu.
(4)department microbiology, new york university school medicine, new york, 
ny, 10016, usa. julio.gallegodelgado@lehman.cuny.edu.
(5)department microbiology, new york university school medicine, new york, 
ny, 10016, usa.

background: tamoxifen oestrogen receptor modulator widely used 
the treatment early stage breast cancer reduction recurrences.
tamoxifen also used powerful research tool controlling gene
expression context cre/loxp site-specific recombination system in
conditional mutant mice.
methods: determine whether administration tamoxifen affects plasmodium 
growth and/or disease outcome malaria, vitro studies assessing effect
of tamoxifen active metabolite 4-hydroxytamoxifen plasmodium
falciparum blood stages performed. tamoxifen effects also evaluated 
vivo treating c57/b6 mice infected plasmodium berghei (anka strain), which
is standard animal model study cerebral malaria.
results: tamoxifen active metabolite, 4-hydroxytamoxifen, show activity
in vitro p. falciparum (16.7 5.8 µm ic50, respectively). activity
was also confirmed tamoxifen-treated mice infected p. berghei, show
lower levels parasitaemia develop signs cerebral malaria,
compared control mice. mice treated tamoxifen 1 week left
untreated additional week infection showed similar parasitaemia
levels signs cerebral malaria control untreated mice.
conclusions: tamoxifen active metabolite, 4-hydroxytamoxifen, have
significant activity human parasite p. falciparum vitro the
rodent parasite p. berghei vivo. activity may useful prevention of
malaria patients taking drug chronically, also represents major
problem scientists using conditional mutagenic cre/loxp system the
setting rodent malaria. allowing mice clear tamoxifen starting a
plasmodium infection allows use cre/loxp conditional mutagenic system 
investigate gene function specific tissues.

doi: 10.1186/s12936-019-3012-7 
pmcid: pmc6882195
pmid: 31775753  [indexed medline]

